Published in J Clin Endocrinol Metab on February 01, 1994
Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res (2007) 3.76
PGE2 induces IL-6 in orbital fibroblasts through EP2 receptors and increased gene promoter activity: implications to thyroid-associated ophthalmopathy. PLoS One (2010) 0.93
Thyrotropin regulates IL-6 expression in CD34+ fibrocytes: clear delineation of its cAMP-independent actions. PLoS One (2013) 0.92
Regulation of Lymphocyte Function by PPARgamma: Relevance to Thyroid Eye Disease-Related Inflammation. PPAR Res (2008) 0.90
Nuclear targeting of IGF-1 receptor in orbital fibroblasts from Graves' disease: apparent role of ADAM17. PLoS One (2012) 0.81
On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Qual Life Res (2003) 3.71
The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol (2000) 3.69
Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol (2001) 3.49
Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf) (1997) 3.44
Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol (1989) 3.02
Carbimazole and the autoimmune response in Graves' disease. N Engl J Med (1980) 2.62
The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev (1998) 2.43
Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial. Clin Endocrinol (Oxf) (2005) 2.34
Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus-induced B-cell lines. Nature (1981) 2.10
Autoantibodies to the thyrotropin receptor. Endocr Rev (1988) 2.02
THE EFFECTS OF THE CARDIAC GLYCOSIDES UPON THE DYNAMICS OF THE CIRCULATION IN CONGESTIVE HEART FAILURE. I. OUABAIN. J Clin Invest (1948) 2.02
Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group. J Clin Oncol (1999) 1.98
Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochem Biophys Res Commun (1989) 1.88
Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease. Thyroid (2000) 1.87
Isolation and characterization of a cDNA clone for porcine thyroid peroxidase. FEBS Lett (1986) 1.80
An enzyme-linked immunoassay for thyroid microsomal antibodies. J Immunol Methods (1982) 1.79
Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy. J Clin Oncol (2003) 1.68
Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy. J Clin Endocrinol Metab (1995) 1.62
Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clin Endocrinol (Oxf) (2000) 1.61
Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents (2007) 1.57
Thyroid-autoantibody synthesis by Hashimoto thyroid lymphocytes. Lancet (1979) 1.52
Beclomethasone inhalation decreases serum osteocalcin concentrations. BMJ (1991) 1.50
Immunoglobulin A in Graves' orbital tissue: deoxyribonucleic acid amplification by polymerase chain reaction. J Endocrinol Invest (1994) 1.41
Use of plaque assays to study thyroglobulin autoantibody synthesis by human peripheral blood lymphocytes. Scand J Immunol (1981) 1.39
Graves' ophthalmopathy: diagnosis and management. Eur J Nucl Med (2000) 1.39
Orbital decompression for Graves' ophthalmopathy by inferomedial, by inferomedial plus lateral, and by coronal approach. Ophthalmology (1990) 1.39
Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL. Br J Ophthalmol (1998) 1.38
Engineering the human thyrotropin receptor ectodomain from a non-secreted form to a secreted, highly immunoreactive glycoprotein that neutralizes autoantibodies in Graves' patients' sera. J Biol Chem (1997) 1.35
The distribution of microsomal and thyroglobulin antibody activity among the IgG subclasses. Clin Exp Immunol (1984) 1.34
Thyroid autoantibody synthesis by cultures of thyroid and peripheral blood lymphocytes. I. Lymphocyte markers and response to pokeweed mitogen. Clin Exp Immunol (1983) 1.34
TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients. Clin Endocrinol (Oxf) (2003) 1.33
Autoantigen recognition by thyroid-infiltrating T cells in Graves disease. Proc Natl Acad Sci U S A (1991) 1.33
Quality of life in patients with Graves' ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid (1997) 1.31
Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments. Clin Endocrinol (Oxf) (2001) 1.30
Thyroid autoimmunity. J Clin Invest (2001) 1.24
A mouse monoclonal antibody to a thyrotropin receptor ectodomain variant provides insight into the exquisite antigenic conformational requirement, epitopes and in vivo concentration of human autoantibodies. J Clin Endocrinol Metab (1999) 1.22
An insertion in the human thyrotropin receptor critical for high affinity hormone binding. Science (1990) 1.21
Highly sensitive assays of autoantibodies to thyroglobulin and to thyroid peroxidase. Clin Chem (1989) 1.20
Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol (2006) 1.19
Evidence that the thyrotropin receptor ectodomain contains not one, but two, cleavage sites. Endocrinology (1997) 1.16
The IgG subclass distribution of thyroglobulin antibody synthesized in culture. Scand J Immunol (1983) 1.16
Extraocular muscle surgery for Graves' ophthalmopathy: does prior treatment influence surgical outcome? Br J Ophthalmol (1990) 1.15
Thyrotropin-luteinizing hormone/chorionic gonadotropin receptor extracellular domain chimeras as probes for thyrotropin receptor function. Proc Natl Acad Sci U S A (1991) 1.15
Clinical experience with a human thyroid cell bioassay for thyroid-stimulating immunoglobulin. J Clin Endocrinol Metab (1984) 1.13
Kinetics of immunoglobulin production by cultured human peripheral blood lymphocytes. J Immunol Methods (1978) 1.13
A prion-like shift between two conformational forms of a recombinant thyrotropin receptor A-subunit module: purification and stabilization using chemical chaperones of the form reactive with Graves' autoantibodies. J Clin Endocrinol Metab (2001) 1.12
[Kaposi's sarcoma and fatal opportunistic infections in a homosexual man with immunodeficiency]. Ned Tijdschr Geneeskd (1983) 1.12
Evidence for negative cooperativity among human thyrotropin receptors overexpressed in mammalian cells. Endocrinology (1996) 1.11
The molecular biology of thyroid peroxidase: cloning, expression and role as autoantigen in autoimmune thyroid disease. Endocr Rev (1992) 1.11
High affinity, thyroid-specific human autoantibodies displayed on the surface of filamentous phage use V genes similar to other autoantibodies. J Immunol (1993) 1.09
Geographical distribution of subclinical autoimmune thyroid disease in Britain: a study using highly sensitive direct assays for autoantibodies to thyroglobulin and thyroid peroxidase. Acta Endocrinol (Copenh) (1990) 1.07
Thyrotoxicosis as a predisposing factor for cerebral venous thrombosis. Thyroid (2000) 1.07
Interrelationships in the regulation of TSH and prolactin secretion in man: effects of L-dopa, TRH and thyroid hormone in various combinations. J Clin Endocrinol Metab (1974) 1.04
TSH receptor antibody synthesis by thyroid lymphocytes. Clin Endocrinol (Oxf) (1986) 1.03
Naked TSH receptor DNA vaccination: A TH1 T cell response in which interferon-gamma production, rather than antibody, dominates the immune response in mice. Endocrinology (2001) 1.03
Bone-alkaline phosphatase as indicator of bone formation. Clin Chim Acta (1991) 1.03
Studies of thyroglobulin autoantibody synthesis using a micro-ELISA assay. Immunol Lett (1982) 1.02
Isolation of a complementary DNA clone for thyroid microsomal antigen. Homology with the gene for thyroid peroxidase. J Clin Invest (1987) 1.02
Thyroid autoantibody synthesis by lymphocytes from different lymphoid organs: fractionation of B cells on density gradients. Immunology (1985) 1.02
Susceptibility rather than resistance to hyperthyroidism is dominant in a thyrotropin receptor adenovirus-induced animal model of Graves' disease as revealed by BALB/c-C57BL/6 hybrid mice. Endocrinology (2004) 1.02
Dog thyroid cells in monolayer tissue culture: adenosine 3', 5'-cyclic monophosphate response to thyrotropic hormone. Endocrinology (1976) 1.02
Thyroid-stimulating immunoglobulin bioassay using cultured human thyroid cells. J Clin Endocrinol Metab (1981) 1.01
A full biological response to autoantibodies in Graves' disease requires a disulfide-bonded loop in the thyrotropin receptor N terminus homologous to a laminin epidermal growth factor-like domain. J Biol Chem (2001) 1.00
Human thyroglobulin autoantibodies of subclasses IgG2 and IgG4 bind to different epitopes on thyroglobulin. Immunology (1989) 0.99
Molecular cloning of the complementary deoxyribonucleic acid for human thyroid peroxidase. Mol Endocrinol (1987) 0.99
Dendritic cells infected with adenovirus expressing the thyrotrophin receptor induce Graves' hyperthyroidism in BALB/c mice. Clin Exp Immunol (2003) 0.99
Control of growth in cultured rat thyroid cells. Mol Cell Endocrinol (1986) 0.98
Thyroid-stimulating autoantibody production in vitro. Nature (1977) 0.98
Hyperresponse to thyrotropin-releasing hormone accompanying small decreases in serum thyroid hormone concentrations. J Clin Invest (1974) 0.97
Studies on the cyclic AMP response to thyroid stimulating immunoglobulin (TSI) and thyrotropin (TSH) in human thyroid cell monolayers. Metabolism (1982) 0.97
The shed thyrotropin receptor is primarily a carboxyl terminal truncated form of the A subunit, not the entire A subunit. Mol Cell Endocrinol (1999) 0.97
The thyrotropin receptor 25 years after its discovery: new insight after its molecular cloning. Mol Endocrinol (1992) 0.96
Test-retest reliability of the GO-QOL: a disease-specific quality of life questionnaire for patients with Graves' ophthalmopathy. J Clin Epidemiol (1999) 0.96
Molecular cloning and partial characterization of a new autoimmune thyroid disease-related antigen. J Clin Endocrinol Metab (1987) 0.96
Thyroid stimulatory autoantibodies in different patients with autoimmune thyroid disease do not all recognize the same components of the human thyrotropin receptor: selective role of receptor amino acids Ser25-Glu30. J Clin Endocrinol Metab (1992) 0.96
Severe combined immunodeficient (SCID) mice: a model for investigating human thyroid autoantibody synthesis. Clin Exp Immunol (1991) 0.95
Enrichment and depletion of thyroglobulin autoantibody synthesizing lymphocytes. Clin Exp Immunol (1983) 0.95
Both Th1- and Th2-derived cytokines in serum are elevated in Graves' ophthalmopathy. Clin Exp Immunol (2000) 0.95
Determination at the molecular level of a B-cell epitope on thyroid peroxidase likely to be associated with autoimmune thyroid disease. J Clin Endocrinol Metab (1991) 0.95
D-Penicillamine-associated myasthenia gravis: immunological and electrophysiological studies. Muscle Nerve (1982) 0.94
Thyrotropin receptors in adipose tissue, retro-orbital tissue and lymphocytes. Mol Cell Endocrinol (1978) 0.94
Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors. J Clin Invest (1991) 0.94
The greater glycan content of recombinant human thyroid peroxidase of mammalian than of insect cell origin facilitates purification to homogeneity of enzymatically protein remaining soluble at high concentration. Endocrinology (1998) 0.94
Serial studies on the affinity and heterogeneity of human autoantibodies to thyroglobulin. Clin Exp Immunol (1989) 0.93